Id
|
Protein
|
PTM type
|
Site
|
Species
|
Disease
|
Celline
|
Drug
|
Regulatory
|
Confidence score
|
Ref.
|
acc2051 |
MEK1 |
phosphorylation |
Ser217 |
human |
Breast Cancer |
SK-BR-3 |
DHA |
Associated |
4.0 |
21771724
|
acc2052 |
MEK1 |
phosphorylation |
Ser221 |
human |
Breast Cancer |
SK-BR-3 |
DHA |
Associated |
4.0 |
21771724
|
acc2053 |
ERK1 |
phosphorylation |
Thr202 |
human |
Lung Cancer |
Calu-6 |
AZD6244 |
Associated |
4.0 |
19783898
|
acc2054 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Lung Cancer |
Calu-6 |
AZD6244 |
Associated |
4.0 |
19783898
|
acc2055 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
HCC2450 |
AZD6244 |
Impairing |
5.0 |
19783898
|
acc2056 |
AKT |
phosphorylation |
Thr308 |
human |
Lung Cancer |
HCC2450 |
AZD6244 |
Impairing |
5.0 |
19783898
|
acc2057 |
ERK2 |
phosphorylation |
Thr185 |
human |
Lung Cancer |
Calu-6 |
AZD6244 |
Associated |
4.0 |
19783898
|
acc2058 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Lung Cancer |
Calu-6 |
AZD6244 |
Associated |
4.0 |
19783898
|
acc2059 |
ERK1 |
phosphorylation |
Thr202 |
human |
Lung Cancer |
HCC2450 |
AZD6244 |
Associated |
4.0 |
19783898
|
acc2060 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Lung Cancer |
HCC2450 |
AZD6244 |
Associated |
4.0 |
19783898
|
acc2061 |
ERK2 |
phosphorylation |
Thr185 |
human |
Lung Cancer |
HCC2450 |
AZD6244 |
Associated |
4.0 |
19783898
|
acc2062 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Lung Cancer |
HCC2450 |
AZD6244 |
Associated |
4.0 |
19783898
|
acc2063 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
H522 |
AZD6244 |
Impairing |
5.0 |
19783898
|
acc2064 |
AKT |
phosphorylation |
Thr308 |
human |
Lung Cancer |
H522 |
AZD6244 |
Impairing |
5.0 |
19783898
|
acc2065 |
MEK |
phosphorylation |
unclear |
human |
Breast Cancer |
MCF7 |
Silibinin |
Associated |
4.0 |
23353996
|
acc2066 |
ERK |
phosphorylation |
unclear |
human |
Breast Cancer |
MCF7 |
Silibinin |
Associated |
4.0 |
23353996
|
acc2067 |
MEK |
phosphorylation |
unclear |
human |
Thyroid Cancer |
TPC-1 |
Silibinin |
Associated |
4.0 |
23353996
|
acc2068 |
ERK |
phosphorylation |
unclear |
human |
Thyroid Cancer |
TPC-1 |
Silibinin |
Associated |
4.0 |
23353996
|
acc2069 |
Bcl-2 |
phosphorylation |
Ser70 |
human |
Leukemia |
HL-60 |
Paclitaxel |
Associated |
4.0 |
10400418
|
acc2070 |
Bcl-2 |
phosphorylation |
Ser70 |
human |
Leukemia |
U937 |
Paclitaxel |
Associated |
4.0 |
10400418
|
acc2071 |
Bcl-2 |
phosphorylation |
Ser70 |
human |
Leukemia |
Jurkat |
Paclitaxel |
Associated |
4.0 |
10400418
|
acc2072 |
ERK1 |
phosphorylation |
Thr202 |
human |
Lung Cancer |
PC9 |
Erlotinib |
Associated |
4.0 |
23979919
|
acc2073 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Lung Cancer |
PC9 |
Erlotinib |
Associated |
4.0 |
23979919
|
acc2074 |
ERK2 |
phosphorylation |
Thr185 |
human |
Lung Cancer |
PC9 |
Erlotinib |
Associated |
4.0 |
23979919
|
acc2075 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Lung Cancer |
PC9 |
Erlotinib |
Associated |
4.0 |
23979919
|
acc2076 |
ERK1 |
phosphorylation |
Thr202 |
human |
Lung Cancer |
HCC827 |
Erlotinib |
Associated |
4.0 |
23979919
|
acc2077 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Lung Cancer |
HCC827 |
Erlotinib |
Associated |
4.0 |
23979919
|
acc2078 |
ERK2 |
phosphorylation |
Thr185 |
human |
Lung Cancer |
HCC827 |
Erlotinib |
Associated |
4.0 |
23979919
|
acc2079 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Lung Cancer |
HCC827 |
Erlotinib |
Associated |
4.0 |
23979919
|
acc2080 |
FAK |
phosphorylation |
Tyr |
human |
Breast Cancer |
MDA-MB-231 |
Met-F-AEA |
Associated |
4.0 |
16343481
|
acc2081 |
Src |
phosphorylation |
Tyr |
human |
Breast Cancer |
MDA-MB-231 |
Met-F-AEA |
Associated |
4.0 |
16343481
|
acc2082 |
FAK |
phosphorylation |
Tyr |
mouse |
Breast Cancer |
TSA-E1 |
Met-F-AEA |
Associated |
4.0 |
16343481
|
acc2083 |
Src |
phosphorylation |
Tyr |
mouse |
Breast Cancer |
TSA-E1 |
Met-F-AEA |
Associated |
4.0 |
16343481
|
acc2084 |
ERK1 |
phosphorylation |
Thr202 |
human |
Melanoma |
Sbcl2 |
Azacitidine |
Associated |
4.0 |
34866327
|
acc2085 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Melanoma |
Sbcl2 |
Azacitidine |
Associated |
4.0 |
34866327
|
acc2086 |
ERK2 |
phosphorylation |
Thr185 |
human |
Melanoma |
Sbcl2 |
Azacitidine + Trametinib |
Associated |
4.0 |
34866327
|
acc2087 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Melanoma |
Sbcl2 |
Azacitidine + Trametinib |
Associated |
4.0 |
34866327
|
acc2088 |
ERK2 |
phosphorylation |
Thr185 |
human |
Melanoma |
Sbcl2 |
Azacitidine |
Associated |
4.0 |
34866327
|
acc2089 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Melanoma |
Sbcl2 |
Azacitidine |
Associated |
4.0 |
34866327
|
acc2090 |
ERK1 |
phosphorylation |
Thr202 |
human |
Melanoma |
Sbcl2 |
Trametinib |
Associated |
4.0 |
34866327
|
acc2091 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Melanoma |
Sbcl2 |
Trametinib |
Associated |
4.0 |
34866327
|
acc2092 |
ERK2 |
phosphorylation |
Thr185 |
human |
Melanoma |
Sbcl2 |
Trametinib |
Associated |
4.0 |
34866327
|
acc2093 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Melanoma |
Sbcl2 |
Trametinib |
Associated |
4.0 |
34866327
|
acc2094 |
ERK1 |
phosphorylation |
Thr202 |
human |
Melanoma |
Sbcl2 |
Azacitidine + Trametinib |
Associated |
4.0 |
34866327
|
acc2095 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Melanoma |
Sbcl2 |
Azacitidine + Trametinib |
Associated |
4.0 |
34866327
|
acc2096 |
MMP-9 |
phosphorylation |
unclear |
human |
Breast Cancer |
MCF7 |
SFN |
Associated |
4.0 |
35988280
|
acc2097 |
MMP-9 |
phosphorylation |
unclear |
human |
Breast Cancer |
MDA-MB-231 |
SFN |
Associated |
4.0 |
35988280
|
acc2098 |
eIF4E |
phosphorylation |
Ser209 |
human |
Leukemia |
MV4-11 |
Merestinib |
Associated |
4.0 |
27307295
|
acc2099 |
eIF4E |
phosphorylation |
Ser209 |
human |
Leukemia |
MM6 |
Merestinib |
Associated |
4.0 |
27307295
|
acc2100 |
KNL1 |
phosphorylation |
Thr875 |
human |
Breast Cancer |
MDA-MB-231 |
Paclitaxel |
Impairing |
5.0 |
31575759
|